Source link : https://www.newshealth.biz/health-news/review-highlights-gi-risks-for-biologic-rxs-for-psoriasis/
TOPLINE: A review of 10 articles finds that nearly 9% of adverse event (AE) reports with biologics used to treat psoriasis were gastrointestinal (GI)-related and suggests that the relative rate may be higher with interleukin (IL)-17 inhibitors than with other biologics. METHODOLOGY: Researchers conducted a systematic review of pharmacovigilance studies on biologic therapies for psoriasis. […]
Author : News Health
Publish date : 2024-10-09 10:48:36
Copyright for syndicated content belongs to the linked Source.
Categories